Publications by authors named "Maria Carmen Vinuela Beneitez"
Article Synopsis
- A predictive model was created to estimate the risk of major bleeding in cancer patients undergoing anticoagulant treatment for venous thromboembolism (VTE) within six months following their diagnosis.
- The study analyzed data from electronic health records across nine hospitals in Spain, using natural language processing and machine learning to identify key predictors of bleeding and develop various predictive algorithms.
- Findings indicated that about 10.9% of the patients experienced major bleeding events after VTE diagnosis, with significant predictors being factors like hemoglobin levels and age, and the new models outperformed the existing CAT-BLEED score.
Introduction: Patients with cancer and venous thromboembolism (VTE) show a high risk of VTE recurrence during anticoagulant treatment. This study aimed to develop a predictive model to assess the risk of VTE recurrence within 6 months at the moment of primary VTE diagnosis in these patients.
Materials And Methods: Using the EHRead® technology, based on Natural Language Processing (NLP) and machine learning (ML), the unstructured data in electronic health records from 9 Spanish hospitals between 2014 and 2018 were extracted.
Risk factors for cancer-associated thrombosis are commonly divided into three categories: patient-, cancer-, and treatment-related factors. Currently, different types of drugs are used in cancer treatment. Chemotherapy has been identified as an independent risk factor for venous thromboembolism (VTE).
View Article and Find Full Text PDFPurpose: Incidentally discovered pulmonary embolism is a prevalent clinical problem for cancer patients and contributes significantly to the burden of cancer-associated thrombosis. The aim of this study was to explore if outpatient management of incidental pulmonary embolism (iPE) in cancer patients is effective and can be conducted safely.
Methods/patients: We performed a prospective observational cohort study in a single Spanish tertiary hospital.
[Consensus statement on monitoring of HIV: pregnancy, birth, and prevention of mother-to-child transmission].
Enferm Infecc Microbiol Clin
May 2014
Objective: The main objective in the management of HIV-infected pregnant women is prevention of mother-to-child transmission; therefore, it is essential to provide universal antiretroviral treatment, regardless of CD4 count. All pregnant women must receive adequate information and undergo HIV serology testing at the first visit.
Methods: We assembled a panel of experts appointed by the Secretariat of the National AIDS Plan (SPNS) and the other participating Scientific Societies, which included internal medicine physicians with expertise in the field of HIV infection, gynecologists, pediatricians and psychologists.